Breaking News Instant updates and real-time market news.

NFLX

Netflix

$220.46

0.13 (0.06%)

, AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

13:32
01/22/18
01/22
13:32
01/22/18
13:32

Notable companies reporting after market close

Notable companies reporting after the market close, with earnings consensus, include Netflix (NFLX), consensus 41c... TD Ameritrade (AMTD), consensus 50c... ResMed (RMD), consensus 78c... Steel Dynamics (STLD), consensus 52c... Zions Bancorp (ZION), consensus 73c... Brown & Brown (BRO), consensus 42c.

NFLX

Netflix

$220.46

0.13 (0.06%)

AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

RMD

ResMed

$88.10

-0.58 (-0.65%)

STLD

Steel Dynamics

$46.42

0.16 (0.35%)

ZION

Zions Bancorp

$53.73

0.87 (1.65%)

BRO

Brown & Brown

$52.13

-0.375 (-0.71%)

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 30

    Jan

  • 16

    Feb

NFLX Netflix
$220.46

0.13 (0.06%)

01/19/18
RSBL
01/19/18
NO CHANGE
Target $265
RSBL
Buy
Netflix price target raised to $265 from $225 at Rosenblatt
Rosenblatt analyst Alan Gould raised his price target on Netflix to $265 from $225 ahead of the company's Q4 earning report, noting that the company has beaten its overall subscriber guidance in 13 of the past 16 quarters. The company's guidance is for 6.3M net sub additions for the fourth quarter, which compares to the consensus forecast for 6.8M net sub additions, Gould noted. He maintains a Buy rating on Netflix shares.
01/19/18
KEYB
01/19/18
NO CHANGE
Target $270
KEYB
Overweight
Netflix price target raised to $270 from $230 at KeyBanc
KeyBanc analyst Andy Hargreaves raised his price target for Netflix to $270 saying the company's upcoming Q4 results "should remain solid." The streaming service closed yesterday up $2.83 to $220.33. The analyst raised his 2018 global net subscriber addition estimate to 20.6M from 19.3M citing sustained growth in the U.S. and an increase to his international total addressable market estimate. He sees potential for upside to subscriber estimates through 2018 and continues to recommend owning shares of Netflix with an Overweight rating. Netflix is the global leader in subscription video in the internet era, Hargreaves tells investors in a research note.
01/18/18
BUCK
01/18/18
NO CHANGE
Target $251
BUCK
Buy
Netflix price target raised to $251 from $235 at Buckingham
Buckingham analyst Matthew Harrigan raised his price target on Netflix to $251 from $235, stating that while his assumptions for the company's upcoming earnings report this Monday are largely in-line with consensus, there could be upside to international streaming additions in the quarter. He also raised his 2018 EPS estimate to $2.49 from $2.37 to account for a lower tax rate assumption. Harrigan keeps a Buy rating on Netflix shares.
01/18/18
MSCO
01/18/18
NO CHANGE
Target $255
MSCO
Overweight
Netflix international net additions estimate raised at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne raised his 2018 international net additions estimate for Netflix to 16.9M subscribers, which he added may still prove conservative. To support this view, he cites Netflix's success in driving a more rapid rate of adoption in younger markets in 2017. Swinburne also raised his price target on Netflix shares to $255 from $235 and keeps an Overweight rating on the stock.
AMTD TD Ameritrade
$55.17

0.21 (0.38%)

01/08/18
LEHM
01/08/18
UPGRADE
Target $68
LEHM
Overweight
TD Ameritrade upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Jeremy Campbell upgraded TD Ameritrade to Overweight and raised his price target for the shares to $68 from $54. Commissions cuts over the next 12 months are a possibility rather than a likelihood, Campbell tells investors in a research note on the U.S. Brokers, Asset Managers & Exchanges sector. The analyst believes TD Ameritrade shares are attractively valued at current levels.
01/16/18
FBCO
01/16/18
NO CHANGE
Target $52
FBCO
Underperform
TD Ameritrade price target raised to $52 from $45 at Credit Suisse
Credit Suisse analyst Craig Siegenthaler raised his price target for TD Ameritrade to $52 from $45 ahead of quarterly results and to include the impacts of U.S. tax reform. The analyst reiterates an Underperform rating on the shares.
01/04/18
WELS
01/04/18
NO CHANGE
Target $67
WELS
Outperform
TD Ameritrade price target raised to $67 from $56 at Wells Fargo
Wells Fargo analyst Chris Harris raised his price target for TD Ameritrade to $67 from $56 to incorporate the benefits of tax reform as well as higher interest rates. The analyst reiterates an Outperform rating on the shares.
01/08/18
GSCO
01/08/18
NO CHANGE
GSCO
Goldman bullish on Brokers into 2018, upgrades Lazard and Stifel
Goldman Sachs analyst Conor Fitzgerald remains bullish on the Brokers and financial service companies heading into 2018. The analyst thinks large-cap mergers and acquisitions could accelerate and financial deals could return. To reflect these trends, Fitzgerald upgraded both Lazard (LAZ) and Stifel Financial (SF) to Buy from Neutral. The analyst prefers E-Trade (ETFC) and Charles Schwab (SCHW) over TD Ameritrade (AMTD) on the belief that commission price cuts are more likely than not in 2018. Further, Fitzgerald views Interactive Brokers' valuation as full and downgraded the shares to Sell from Neutral. Lastly, he sees a more balanced risk/reward for MarketAxess (MKTX) in this low volatility environment and downgraded the shares to Neutral from Buy.
RMD ResMed
$88.10

-0.58 (-0.65%)

08/02/17
SBSH
08/02/17
UPGRADE
SBSH
Buy
ResMed upgraded to Buy from Neutral at Citi
Citi analyst Victor Windeyer upgraded ResMed to Buy with following the company's Q4 results. Credit Suisse and BofA/Merrill downgraded the shares this morning. The analyst believes supply bottlenecks have been removed and that the mask category can return to growth. He raised his price target for ResMed shares to A$10.50 from A$10.
12/12/17
BMOC
12/12/17
NO CHANGE
Target $82
BMOC
Market Perform
ResMed price target raised to $82 from $74 at BMO Capital
BMO Capital analyst Joanne Wuensch raised her price target on ResMed to $82 as part of her "2018 MedTech Outlook" report, saying the company is at the "beginning of a new product cycle for its masks, including the launch of its AirF it F20, AirFit N20, and AirTouch F20". These masks, the analyst contends, come with higher gross margins and should also be better received by patients because of their greater comfort. Wuensch also notes the management's focus on expenses, having reorganized the company into sleep, respiratory, and software-as-a-service to streamline infrastructure and improve communication. The analyst keeps her Market Perform rating on ResMed.
08/02/17
08/02/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Neutral from Buy at Citi with analyst Kate McShane citing yesterday's guide-down, the shares look "too expensive for investors to jump into the name nearer-term." 2. Burlington Stores (BURL) downgraded to Neutral from Outperform at Credit Suisse with analyst Christian Buss saying that although the fundamentals of the company remain healthy, he sees limited upside to valuation as the multiples stay elevated despite more moderate industry growth prospects. 3. Big 5 Sporting (BGFV) downgraded to Hold from Buy at Deutsche Bank with analyst Mike Baker saying he expected Big Five's sales gains following The Sports Authority liquidation would decelerate at some point, but he notes that "trends fell off faster and to a greater extent than we suspected." 4. Ultimate Software (ULTI) downgraded to Hold from Buy at Deutsche Bank with analyst Nandan Amladi calling the second quarter results "mixed" and prefers to move to the sidelines until growth returns to the mid-20s target and leverage returns to the model. 5. ResMed (RMD) was downgraded to Neutral from Buy at BofA/Merrill and to Neutral from Outperform at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/02/17
08/02/17
DOWNGRADE

Neutral
ResMed downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Saul Hadassin downgraded ResMed to Neutral from Outperform following the company's Q4 in line earnings. The analyst also lowered his price target on the shares to A$9.40 from A$9.70.
STLD Steel Dynamics
$46.42

0.16 (0.35%)

01/22/18
SBSH
01/22/18
UPGRADE
Target $43
SBSH
Neutral
U.S. Steel upgraded to Neutral from Sell at Citi
Citi analyst Alexander Hacking upgraded U.S. Steel to Neutral and raised his price target for the shares to $43 from $22. The analyst sees steel prices better supported near-term and increased his EBITDA estimates. Expectations for longer term "normalized" earnings should improve to justify current valuation levels, Hacking tells investors in a research note on the Steel sector. His top picks remain Steel Dynamics (STLD), Nucor (NUE) and Commercial Metals (CMC). The analyst raised his price targets for those stocks to $54 from $42, $79 from $66 and $29 from $21, respectively.
01/08/18
BOFA
01/08/18
NO CHANGE
Target $51
BOFA
Buy
Steel Dynamics price target raised to $51 from $45 at BofA/Merrill
BofA/Merrill analyst Timna Tanners raised her price target for Steel Dynamics to $51 from $45 as she believes U.S. benchmark steel prices will surge past $700 as 2018 starts with a bang. The analyst reiterates a Buy rating on the shares.
12/29/17
JEFF
12/29/17
NO CHANGE
JEFF
Jefferies positive on U.S. steelmakers after talking to recyclers
Jefferies analyst Seth Rosenfeld says recyclers he contacted this week expect January scrap prices to move up $20-$30 per ton sequentially on average. Recyclers pointed to three key factors driving prices: robust export demand, frigid weather adversely impacting inbound flows and improved domestic demand post the holiday lull, Rosenfeld tells investors in a research note. With sentiment remaining positive into the new year, the analyst finds it probable that flat rolled producers will introduce an incremental price hike to expand metal spreads post January's scrap settlement. He remains positive on U.S. steelmakers, specifically his top picks Steel Dynamics (STLD), U.S. Steel (X), Nucor (NUE), ArcelorMittal (MT) and Commercial Metals (CMC).
12/21/17
MSCO
12/21/17
NO CHANGE
MSCO
Equal Weight
Cleveland-Cliffs a key beneficiary of corporate AMT repeal, says Morgan Stanley
Morgan Stanley analyst Piyush Sood noted that Steel Dynamics (STLD) and Nucor (NUE) have been the "preferred tax reform plays" in the steel sector, but he believes that Cleveland-Cliffs (CLF), as well as Warrior Met Coal (HCC) and Freeport McMoran (FCX), should benefit from the corporate alternative minimum tax repeal, as they all carry substantial AMT credits on their balance sheets. He keeps Equal Weight ratings on Cleveland, Warrior and Freeport.
ZION Zions Bancorp
$53.73

0.87 (1.65%)

10/02/17
BARD
10/02/17
DOWNGRADE
Target $43
BARD
Underperform
Zions Bancorp downgraded to Underperform at Baird
As reported previously, Baird analyst David George downgraded Zions Bancorp to Underperform from Neutral based on valuation. The analyst sees the need for accelerating loan growth and improvement in operating leverage to further narrow the spread in core returns versus peers. George has a $43 price target on Zions Bancorp shares.
11/15/17
MSCO
11/15/17
NO CHANGE
MSCO
Morgan Stanley says higher SIFI threshold could benefit Comerica, CIT, Zions
After Senate Banking Committee Chairman Mike Crapo proposed a bill in the Senate that would effectively remove the SIFI threshold for banks under $250B, Morgan Stanley analyst Ken Zerbe estimated that banks with $50B-$100B in assets could see a 12% increase in 2020 EPS and a 15% bump in 2021. He sees the largest potential increase at Comerica (CMA), followed by CIT Group (CIT) and Zions Bancorp (ZION). Zerbe projects the least EPS benefit for SunTrust (STI), Regions Financial (RF), Ally Financial (ALLY) and Discover (DFS), he tells investors. Other banks he lists in his note as potentially impacted by SIFI and CCAR changes include Synchrony (SYF), M&T Bank (MTB), KeyCorp (KEY), Fifth Third (FITB), BB&T (BBT), Citizens Financial (CFG) and Huntington Bancshares (HBAN).
11/21/17
SPHN
11/21/17
NO CHANGE
SPHN
Equal Weight
Zions petition to escape SIFI designation 'no great surprise,' says Stephens
Stephens analyst Terry McEvoy said Zions Bancorp's (ZION) plan to petition the Financial Stability Oversight Committee to remove its designation as a systematically important financial institution, or SIFI, is "no great surprise" given the bank's prior commentary, but is still an overall positive for the stock. The news can also be potentially positive for other "over-capitalized and less-complex" super regional banks, such as Comerica (CMA), Citizens Financial (CFG) and Regions Financial (RF), added McEvoy. The analyst keeps an Equal Weight rating on Zions shares.
12/12/17
KBWI
12/12/17
UPGRADE
Target $53
KBWI
Outperform
Zions Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Klock upgraded Zions Bancorp to Outperform and raised his price target for the shares to $53 from $48.
BRO Brown & Brown
$52.13

-0.375 (-0.71%)

12/06/17
RHCO
12/06/17
UPGRADE
Target $63
RHCO
Buy
Brown & Brown upgraded to Buy at SunTrust on gains in Florida market
As noted earlier, SunTrust analyst Mark Hughes upgraded Brown & Brown to Buy from Hold and raised his price target to $63 from $52. Hughes notes the company stands to benefit from commission gains in the Florida market, contribution from the company's sales incentive program, reduced investments costs, and the anticipated tax reform impact which could add up to 55c to the FY19 EPS target of $2.25. The analyst is especially positive on the Florida market impact, where post-Irma moratorium rolls off after 90 days, leading to property insurance rates going up 5%-20%.
11/08/17
SBSH
11/08/17
DOWNGRADE
Target $47
SBSH
Sell
Brown & Brown downgraded to Sell from Neutral at Citi
Citi analyst James Naklicki downgraded Brown & Brown to Sell saying the shares are now overvalued following a 36% run since the election. The analyst cut his price target for the stock to $47 from $49. He sees Brown & Brown's earnings growth being just 5%-6% over the next three years, or much lower than its peers.
12/06/17
RHCO
12/06/17
UPGRADE
RHCO
Buy
Brown & Brown upgraded to Buy from Hold at SunTrust
12/06/17
12/06/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AIG (AIG) upgraded to Hold from Sell at Deutsche Bank with analyst Joshua Shanker sayign the stock "might have found a bottom" after dropping 8% since the third quarter results on November 2. Brown & Brown (BRO) upgraded to Buy from Hold at SunTrust with analyst Mark Hughes saying the company stands to benefit from commission gains in the Florida market, contribution from the company's sales incentive program, reduced investments costs, and the anticipated tax reform impact which could add up to 55c to the fiscal 2019 earnings per share target of $2.25. 3. L3 Technologies (LLL) upgraded to Outperform from Sector Perform at RBC Capital with analyst Matt McConnell citing the company's investor day presentation. McConnell says the event highlighted the company's position combining the "best-in-defense runway for operating margin improvement, near-term organic growth acceleration, and bolt-on M&A potential". 4. Carnival (CCL) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Jamie Rollo stating that the firm's survey of U.S. travel agents suggested strong demand for cruises in November, which he notes is usually a slow month for bookings. 5. Express Scripts (ESRX) upgraded to Market Perform from Underperform at Bernstein with the firm citing improved upside risks from potential policy and competitor actions and valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CCB

Coastal Financial

$0.00

(0.00%)

21:11
07/17/18
07/17
21:11
07/17/18
21:11
Syndicate
Coastal Financial 2.85M share IPO priced at $14.50 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CRNX

Crinetics

$0.00

(0.00%)

21:08
07/17/18
07/17
21:08
07/17/18
21:08
Syndicate
Crinetics 6M share IPO priced at $17.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

NSTG

NanoString

$12.74

-2.36 (-15.63%)

21:07
07/17/18
07/17
21:07
07/17/18
21:07
Syndicate
NanoString 4M share Secondary priced at $12.50 »

JPMorgan and UBS acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

  • 18

    Jul

ALV

Autoliv

$106.86

1.57 (1.49%)

21:06
07/17/18
07/17
21:06
07/17/18
21:06
Downgrade
Autoliv rating change  »

Autoliv downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VC

Visteon

$131.71

3.58 (2.79%)

21:06
07/17/18
07/17
21:06
07/17/18
21:06
Downgrade
Visteon rating change  »

Visteon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 07

    Aug

ABT

Abbott

$62.84

1.05 (1.70%)

, MS

Morgan Stanley

$49.20

0.29 (0.59%)

20:25
07/17/18
07/17
20:25
07/17/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

ABT

Abbott

$62.84

1.05 (1.70%)

MS

Morgan Stanley

$49.20

0.29 (0.59%)

USB

U.S. Bancorp

$51.29

-0.01 (-0.02%)

TXT

Textron

$66.81

0.14 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

ADTN

Adtran

$16.05

0.1 (0.63%)

20:14
07/17/18
07/17
20:14
07/17/18
20:14
Earnings
Adtran reports Q2 adjusted EPS (10c), two estimates (32c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

FSBW

FS Bancorp

$61.64

-1.86 (-2.93%)

, ANCB

Anchor Bancorp

$28.50

0.3 (1.06%)

20:09
07/17/18
07/17
20:09
07/17/18
20:09
Hot Stocks
FS Bancorp to merge with Anchor Bancorp in $77M deal »

FS Bancorp (FSBW) and…

FSBW

FS Bancorp

$61.64

-1.86 (-2.93%)

ANCB

Anchor Bancorp

$28.50

0.3 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$26.41

-1.19 (-4.31%)

20:06
07/17/18
07/17
20:06
07/17/18
20:06
Hot Stocks
Breaking Hot Stocks news story on Canopy Growth  »

Greenstar Canada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$356.95

0.94 (0.26%)

19:10
07/17/18
07/17
19:10
07/17/18
19:10
Hot Stocks
Boeing awarded $3.9B government contract »

Boeing has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MRTN

Marten Transport

$22.10

(0.00%)

, UAL

United Continental

$72.66

0.38 (0.53%)

19:03
07/17/18
07/17
19:03
07/17/18
19:03
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Martin…

MRTN

Marten Transport

$22.10

(0.00%)

UAL

United Continental

$72.66

0.38 (0.53%)

CSX

CSX

$64.42

0.46 (0.72%)

MLNX

Mellanox

$84.85

0.9 (1.07%)

IBKR

Interactive Brokers

$64.65

1.93 (3.08%)

HCSG

Healthcare Services

$42.38

-0.3297 (-0.77%)

TXN

Texas Instruments

$115.80

1.21 (1.06%)

SAH

Sonic Automotive

$20.45

0.3 (1.49%)

CARA

Cara Therapeutics

$21.60

0.435 (2.06%)

CASI

Casi Pharmaceuticals

$7.26

-0.215 (-2.88%)

TLYS

Tilly's

$15.35

0.21 (1.39%)

CLX

Clorox

$135.00

0.71 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 18

    Jul

  • 18

    Jul

  • 24

    Jul

  • 02

    Aug

  • 26

    Aug

  • 19

    Jul

BHP

BHP Billiton

$48.73

0.24 (0.49%)

18:38
07/17/18
07/17
18:38
07/17/18
18:38
Hot Stocks
BHP Billiton sees FY19 copper equivalent output broadly in line with FY18 »

Says expects to achieve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$48.73

0.24 (0.49%)

18:35
07/17/18
07/17
18:35
07/17/18
18:35
Hot Stocks
BHP Billiton reports Q4 petroleum production 49 MMBOE, down 6% »

Reports Q4 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$135.00

0.71 (0.53%)

18:31
07/17/18
07/17
18:31
07/17/18
18:31
Downgrade
Clorox rating change at Goldman Sachs »

Clorox downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

NCS

NCI Building

$20.70

0.15 (0.73%)

18:27
07/17/18
07/17
18:27
07/17/18
18:27
Hot Stocks
NCI Building Systems, Ply Gem Parent to combine in stock-for-stock merger »

NCI Building Systems and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMX

America Movil, also tag AMOV

$17.39

-0.35 (-1.97%)

, AMOV

America Movil, also tag AMX

$17.45

-0.19 (-1.08%)

18:16
07/17/18
07/17
18:16
07/17/18
18:16
Earnings
America Movil reports Q2 operating profit MXN32.6M, up 4.8% from last year »

Reports Q2 revenue…

AMX

America Movil, also tag AMOV

$17.39

-0.35 (-1.97%)

AMOV

America Movil, also tag AMX

$17.45

-0.19 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,844.00

21.98 (1.21%)

18:08
07/17/18
07/17
18:08
07/17/18
18:08
Recommendations
Amazon.com analyst commentary at Piper Jaffray »

Amazon.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 16

    Aug

BRK.A

Berkshire Hathaway

$288,482.00

-1118 (-0.39%)

, BRK.B

Berkshire Hathaway

$190.47

-1.52 (-0.79%)

18:06
07/17/18
07/17
18:06
07/17/18
18:06
Hot Stocks
Berkshire Hathaway amends share repurchase program »

The Board of Directors of…

BRK.A

Berkshire Hathaway

$288,482.00

-1118 (-0.39%)

BRK.B

Berkshire Hathaway

$190.47

-1.52 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNFP

Pinnacle Financial

$60.10

-0.5 (-0.83%)

18:02
07/17/18
07/17
18:02
07/17/18
18:02
Earnings
Pinnacle Financial reports Q2 EPS $1.15, consensus $1.14 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 24

    Sep

CHDN

Churchill Downs

$304.60

1.1 (0.36%)

18:02
07/17/18
07/17
18:02
07/17/18
18:02
Hot Stocks
Churchill Downs receives approval to increase historical racing machines »

Churchill Downs announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

CE

Celanese

$110.22

1.6 (1.47%)

18:01
07/17/18
07/17
18:01
07/17/18
18:01
Hot Stocks
Celanese announces acetic acid price increases in Asia »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

BLK

BlackRock

$504.89

1.14 (0.23%)

17:51
07/17/18
07/17
17:51
07/17/18
17:51
Hot Stocks
BlackRock raises quarterly dividend to $3.13 from $2.88 per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRNA

Dicerna

$12.47

0.57 (4.79%)

17:45
07/17/18
07/17
17:45
07/17/18
17:45
Conference/Events
Dicerna management to meet with SunTrust »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

GOOG

Alphabet

$1,198.81

14.57 (1.23%)

, GOOGL

Alphabet Class A

$1,213.65

17.07 (1.43%)

17:44
07/17/18
07/17
17:44
07/17/18
17:44
Periodicals
Google faces record EU fine over Android dominance, FT reports »

Alphabet's Google…

GOOG

Alphabet

$1,198.81

14.57 (1.23%)

GOOGL

Alphabet Class A

$1,213.65

17.07 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 23

    Jul

  • 23

    Jul

  • 08

    Aug

  • 18

    Sep

  • 28

    Oct

BA

Boeing

$356.95

0.94 (0.26%)

17:39
07/17/18
07/17
17:39
07/17/18
17:39
Periodicals
Breaking Periodicals news story on Boeing »

Boeing awarded $3.9B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.